Methods and Compositions for Prevention and Mitigation of Radiation-Induced Cardiac Injury Using GLP-1 Receptor Agonists
This technology utilizes glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide, to prevent and treat radiation-induced cardiac injury, offering a novel medical approach to protect the heart from damages caused by ionizing radiation.
Background:
Radiation-induced heart disease (RIHD) is a serious complication arising from exposure...
Published: 6/12/2026
|
Inventor(s): Snehalata Pawar, Suresh Veeraperumal
Keywords(s): cardiovascular, Technologies
Category(s): Campus > Upstate Medical University, Technology Classifications > Therapeutics and Vaccines
|